Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 382.80
+0.90 (0.24%)
Apr 10, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 178.35 billion as of April 10, 2026. Its market cap has decreased by -7.45% in one year.
Market Cap
178.35B
Enterprise Value
198.74B
Revenue
31.05B
Ranking
n/a
PE Ratio
41.00
Stock Price
382.80
Market Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 178.35B, an increase of 1,160.59%. That is a compound annual growth rate of 10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 178.35B | -6.08% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 397.41B |
| Danske Bank | 265.68B |
| A.P. Møller - Mærsk | 227.03B |
| Ørsted | 217.38B |
| Vestas Wind Systems | 194.69B |
| Carlsberg | 116.96B |
| Genmab | 109.89B |
| Coloplast | 96.48B |